Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease

NCT06902987 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Diseases
Active Anal Fistula
Upadacitinib

Interventions

DRUG: Upadacitinib

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University